Falls are the leading cause of injury and hospitalization among adults over the age of 65 in Canada. Worldwide, about a third of older adults fall each year, with many requiring medical care to recover or losing their capacity to live independently.

A study published in Nature Medicine has uncovered biomarkers that could help select the most effective precision treatments for patients with late-stage prostate cancer. Led by Vancouver Coastal Health Research Institute researcher Dr.

Sleep apnea is a common condition in which breathing repeatedly stops or becomes shallow during sleep, leading to poor rest and excessive fatigue. The most common type is obstructive sleep apnea (OSA), which affects an estimated one billion people worldwide. It occurs when the upper airway becomes blocked, often accompanied by snoring. 

Sexual health can be an uncomfortable topic of conversation for patients, some of whom may prefer more discrete options for sharing intimate details. In a first-of-its-kind study, Vancouver Coastal Health Research Institute (VCHRI) researchers have demonstrated the viability of the PenoMeter novel mobile option for diagnosing Peyronie’s disease. 

A collaborative team of researchers from the Department of Chemistry at the University of British Columbia (UBC) and the Vancouver Prostate Centre (VPC) have developed a new method to design safer, more targeted cancer drugs. The platform, called baited-SELEX, uses DNA molecules to mimic antibodies and selectively target cancer cells while minimizing harmful side effects of current therapies.

Every year, the Vancouver Coastal Health Research Institute (VCHRI) Research Challenge gives front-line staff and clinicians the tools, funding and mentorship to lead research projects. By pairing point-of-care Vancouver Coastal Health (VCH) health care providers with experienced VCHRI researchers, the program helps transform real-world questions into evidence-based answers to improve patient care.

I am pleased to announce the appointment of Dr. David A. Wood as the inaugural Chief Scientific Officer of the Dilwari Cardiovascular Institute, for a five-year term to May 19, 2030.

A technology used in advanced brain and lung cancer surgery is now being explored in the removal of prostate cancer. The first-of-its-kind study — led by Vancouver Coastal Health Research Institute researcher Dr. Miles Mannas — applied cutting-edge stimulated Raman histology (SRH) to rapidly analyze tissue biopsies during robotic radical prostatectomy, significantly reducing surgical times while enhancing cancerous tissue removal.